Actively Recruiting
Barts Endocarditis Research Registry for Patients with Infective Endocarditis
Led by Queen Mary University of London · Updated on 2025-07-15
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are establishing the Barts Endocarditis Research Registry to study Infective Endocarditis (IE) in their patient population. The registry aims to assess the characteristics of IE, the use of imaging techniques, and how European Society of Cardiology (ESC) guidelines affect patient prognosis. This research will improve diagnosis and management, forming the foundation for future studies, including interventional trials to evaluate treatments and outcomes. The registry collects detailed information on epidemiology, demographics, microbiology, surgery, and patient outcomes. It tracks patients admitted with IE, those attending outpatient clinics, and patients with cardiac device-related infections. The multidisciplinary team discusses cases weekly to ensure consistent, evidence-based care. Data collection spans up to 10 years, supporting the evaluation of mortality, morbidity, reinfection, and relapse rates. Participants provide informed consent and are monitored through regular data collection on their infection status, treatments, and outcomes. Researchers review imaging findings, infectious organisms, and pathological markers to better understand their relationship to patient health. This long-term registry supports ongoing safety reviews and helps shape future research to improve care for IE patients.
CONDITIONS
Brief Title
Barts Endocarditis Research Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 16 and over
- Patients admitted to Barts Heart Centre with confirmed Endocarditis
- Patients attending outpatients with confirmed or suspected Endocarditis
- Patients with possible Infective Endocarditis who complete treatment
- Patients with cardiac device related Endocarditis
- Patients able to provide informed consent
You will not qualify if you...
- Patients with pacemaker pocket infection without pacemaker lead or valve infection
- Patients who refuse consent to be included in the research database
- Patients with "rejected" endocarditis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants who undergo routine care for infective endocarditis are observed over time to collect data on disease characteristics, treatment outcomes, and complications.
Visits as part of routine clinical care and follow-up
Trial Site Locations
Total: 1 location
1
St Bartholomews Hospital
London, United Kingdom
Actively Recruiting
Research Team
I
Innocent Bvekerwa, MSc
S
Simon Woldman
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here